Abstract:Background: Kleefstra syndrome spectrum (KLEFS) is an autosomal dominant disorder that can lead to intellectual disability and autism spectrum disorders. KLEFS encompasses Kleefstra syndrome-1 (KLEFS1) and Kleefstra syndrome-2 (KLEFS2), with KLEFS1 accounting for more than 75%. However, limited information is available regarding KLEFS2. KLEFS1 is caused by a subtelomeric chromosomal abnormality resulting in either deletion at the end of the long arm of chromosome 9, which contains the EHMT1 gene, or by variants in the EHMT1 gene and the KMT2C gene that cause KLEFS2. Methods: This study was a retrospective analysis of clinical data from four patients with KLEFS. Exome sequencing (ES) and Sanger sequencing techniques were used to identify and validate the candidate variants, facilitating the analysis of genotype‒phenotype correlations of the EHMT1 and KMT2C genes. Protein structure modeling was performed to evaluate the effects of the variants on the protein's three-dimensional structure. In addition, real-time quantitative reverse transcription‒polymerase chain reaction (RT‒qPCR) and western blotting were used to examine the protein and mRNA levels of the KMT2C gene. Results: Two patients with KLEFS1 were identified: one with a novel variant (c.2382 + 1G > T) and the other with a previously reported variant (c.2426 C > T, p.Pro809Leu) in the EHMT1 gene. A De novo deletion at the end of the long arm of chromosome 9 was also reported. Furthermore, a patient with KLEFS2 was identified with a novel variant in the KMT2C gene (c.568 C > T, p.Arg190Ter). The RT‒qPCR and western blot results revealed that the expression of the KMT2C gene was downregulated in the KLEFS2 sample. Conclusion: This study contributes to the understanding of both KLEFS1 and KLEFS2 by identifying novel variants in EHMT1 and KMT2C genes, thereby expanding the variant spectrum. Additionally, we provide the first evidence of how a KMT2C variant leads to decreased gene and protein expression, enhancing our understanding of the molecular mechanisms underlying KLEFS2. Based on these findings, children exhibiting developmental delay, hypotonia, distinctive facial features, and other neurodevelopmental abnormalities should be considered for ES to ensure early intervention and treatment.

A novel 11 base pair deletion in KMT2C resulting in Kleefstra syndrome 2

Novel germline variants in KMT2C in Chinese patients with Kleefstra syndrome-2

Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes

EHMT2 LOSS-OF-FUNCTION ALTERATIONS CAUSE A KLEEFSTRA-LIKE SYNDROME

Clinical characteristics and genetic analysis of four pediatric patients with Kleefstra syndrome

Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

Identification of Novel KMT2D Mutations in Two Chinese Children with Kabuki Syndrome: a Case Report and Systematic Literature Review

Novel heterozygous variants in KMT2D associated with holoprosencephaly

EHMT2 as a Candidate Gene for an Autosomal Recessive Neurodevelopmental Syndrome

[Two Novel and De Novo KMT2D Mutations on the Same Allele Cause Kabuki Syndrome].

Clinical Phenotypes and Molecular Findings in Ten Chinese Patients with Kleefstra Syndrome Type 1 Due to EHMT1 Defects.

Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1

Variants in KMT2A in Three Individuals with Previous Suspicion of 22q11.2 Deletion Syndrome

X-Linked Intellectual Disability, A Novel KDM5C Variation: A Case Report

Further Delineation of the Phenotype of Truncating KMT2A Mutations: the Extended Wiedemann-Steiner Syndrome.

Tourette-like syndrome secondary to Kleefstra syndrome 1 with a de novo microdeletion in the EHMT1 gene

Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki Syndrome

Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C

Kabuki Syndrome: Novel Pathogenic Variants, New Phenotypes and Review of Literature